Aureus Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.4M | Sell |
76,103
-730
| -1% | -$396K | 2.49% | 17 |
|
|
2025
Q4 | $44.5M | Sell |
76,833
-250
| -0.3% | -$141K | 2.84% | 13 |
|
|
2025
Q3 | $37.4M | Sell |
77,083
-1,188
| -2% | -$553K | 2.43% | 15 |
|
|
2025
Q2 | $31.7M | Buy |
78,271
+21,784
| +39% | +$9.11M | 2.03% | 21 |
|
|
2025
Q1 | $28.1M | Sell |
56,487
-495
| -0.9% | -$268K | 1.97% | 22 |
|
|
2024
Q4 | $29.6M | Sell |
56,982
-945
| -2% | -$520K | 1.92% | 22 |
|
|
2024
Q3 | $35.8M | Sell |
57,927
-477
| -0.8% | -$282K | 2.34% | 17 |
|
|
2024
Q2 | $32.3M | Sell |
58,404
-910
| -2% | -$521K | 2.26% | 19 |
|
|
2024
Q1 | $34.5M | Sell |
59,314
-11
| -0% | -$6.17K | 2.35% | 19 |
|
|
2023
Q4 | $31.5M | Sell |
59,325
-757
| -1% | -$366K | 2.3% | 20 |
|
|
2023
Q3 | $30.4M | Sell |
60,082
-2,070
| -3% | -$1.1M | 2.44% | 16 |
|
|
2023
Q2 | $32.4M | Buy |
62,152
+11,177
| +22% | +$6.03M | 2.43% | 16 |
|
|
2023
Q1 | $29.4M | Buy |
50,975
+30
| +0.1% | +$16.9K | 2.32% | 20 |
|
|
2022
Q4 | $28.1M | Buy |
50,945
+291
| +0.6% | +$154K | 2.42% | 19 |
|
|
2022
Q3 | $25.7M | Sell |
50,654
-958
| -2% | -$536K | 2.24% | 20 |
|
|
2022
Q2 | $28M | Buy |
51,612
+135
| +0.3% | +$74.3K | 2.26% | 18 |
|
|
2022
Q1 | $30.4M | Sell |
51,477
-18,477
| -26% | -$10.6M | 2.02% | 21 |
|
|
2021
Q4 | $46.7M | Sell |
69,954
-895
| -1% | -$559K | 2.88% | 8 |
|
|
2021
Q3 | $40.5M | Buy |
70,849
+1,577
| +2% | +$866K | 2.66% | 10 |
|
|
2021
Q2 | $34.9M | Buy |
69,272
+2,249
| +3% | +$1.06M | 2.25% | 15 |
|
|
2021
Q1 | $30.6M | Buy |
67,023
+2,821
| +4% | +$1.35M | 2.37% | 15 |
|
|
2020
Q4 | $29.9M | Buy |
64,202
+591
| +0.9% | +$277K | 2.52% | 11 |
|
|
2020
Q3 | $28.1M | Buy |
63,611
+2,354
| +4% | +$973K | 2.66% | 14 |
|
|
2020
Q2 | $22.2M | Buy |
61,257
+986
| +2% | +$330K | 2.42% | 15 |
|
|
2020
Q1 | $17.1M | Buy |
60,271
+240
| +0.4% | +$75.7K | 2.37% | 17 |
|
|
2019
Q4 | $19.5M | Buy |
60,031
+572
| +1% | +$173K | 2.18% | 21 |
|
|
2019
Q3 | $17.3M | Sell |
59,459
-497
| -0.8% | -$142K | 2.16% | 21 |
|
|
2019
Q2 | $17.6M | Buy |
59,956
+1,550
| +3% | +$427K | 2.17% | 21 |
|
|
2019
Q1 | $16M | Buy |
58,406
+2,887
| +5% | +$718K | 2.12% | 23 |
|
|
2018
Q4 | $12.4M | Sell |
55,519
-6,553
| -11% | -$1.54M | 1.95% | 24 |
|
|
2018
Q3 | $15.2M | Sell |
62,072
-400
| -0.6% | -$92K | 1.93% | 25 |
|
|
2018
Q2 | $12.9M | Buy |
62,472
+3,170
| +5% | +$673K | 1.78% | 27 |
|
|
2018
Q1 | $12.2M | Buy |
59,302
+1,682
| +3% | +$353K | 1.84% | 28 |
|
|
2017
Q4 | $10.9M | Buy |
57,620
+299
| +0.5% | +$57.3K | 1.69% | 29 |
|
|
2017
Q3 | $10.8M | Sell |
57,321
-29,101
| -34% | -$5.27M | 1.72% | 31 |
|
|
2017
Q2 | $15.1M | Sell |
86,422
-20,920
| -19% | -$3.51M | 2.54% | 12 |
|
|
2017
Q1 | $18.4M | Sell |
107,342
-1,305
| -1% | -$199K | 3.19% | 2 |
|
|
2016
Q4 | $15.3M | Buy |
108,647
+4,650
| +4% | +$686K | 3% | 6 |
|
|
2016
Q3 | $16.5M | Sell |
103,997
-397
| -0.4% | -$61.2K | 3.31% | 2 |
|
|
2016
Q2 | $15.4M | Buy |
104,394
+4,375
| +4% | +$646K | 3.32% | 4 |
|
|
2016
Q1 | $14.2M | Buy |
100,019
+2,380
| +2% | +$319K | 3.09% | 5 |
|
|
2015
Q4 | $13.8M | Buy |
97,639
+9,488
| +11% | +$1.27M | 3.11% | 6 |
|
|
2015
Q3 | $10.8M | Buy |
88,151
+1,781
| +2% | +$232K | 2.68% | 14 |
|
|
2015
Q2 | $11.2M | Buy |
86,370
+6,120
| +8% | +$798K | 2.36% | 15 |
|
|
2015
Q1 | $10.8M | Buy |
80,250
+5,200
| +7% | +$670K | 2.48% | 9 |
|
|
2014
Q4 | $9.4M | Buy |
75,050
+10,490
| +16% | +$1.28M | 2.29% | 17 |
|
|
2014
Q3 | $7.86M | Buy |
64,560
+61,020
| +1,724% | +$7.42M | 1.97% | 23 |
|
|
2014
Q2 | $418K | Sell |
3,540
-350
| -9% | -$41.2K | 0.1% | 85 |
|
|
2014
Q1 | $468K | Buy |
+3,890
| New | +$462K | 0.12% | 97 |
|
Other funds holding TMO
VCM
Aureus Asset Management's TMO Position: Q1 2026 in Review
Aureus Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.95% in Q1 2026, selling an estimated $396K and leaving 76,103 shares worth $37.4M. The position accounts for 2.49% of the portfolio, ranked #17.
Aureus Asset Management first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $46.7M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Aureus Asset Management held 76,103 shares of Thermo Fisher Scientific worth $37.4M as of Q1 2026.
- Aureus Asset Management sold 730 Thermo Fisher Scientific shares in Q1 2026, an estimated $396K.
- Thermo Fisher Scientific made up 2.49% of Aureus Asset Management's portfolio in Q1 2026, its #17 holding.
- Aureus Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
- Aureus Asset Management's Thermo Fisher Scientific position peaked at $46.7M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.